Oramed ends subject enrolment in Phase II trial of oral insulin for NASH
Oramed Pharmaceuticals concluded enrolment in a Phase II trial of oral insulin capsule, ORMD-0801, to treat non-alcoholic steatohepatitis.
Stay updated with breaking news from Cellular Immune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oramed Pharmaceuticals concluded enrolment in a Phase II trial of oral insulin capsule, ORMD-0801, to treat non-alcoholic steatohepatitis.
Pfizer has announced that the company will not commence any new clinical trials in Russia amid the Ukraine crisis.
Russia is dependent on Taiwan's semiconductors for everything from the manufacture of laptops to military equipment.
Many foreign companies operating in Ukraine have swiftly moved to support the country as it defends itself from the Russian invasion.
The companies have reported positive study results after a series of delays to the Sanofi-GSK vaccine’s development.